- Home
- BLFS
as 11-17-2025 3:44pm EST
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.3B | IPO Year: | 1989 |
| Target Price: | $30.60 | AVG Volume (30 days): | 327.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $19.10 - $29.62 | Next Earning Date: | 11-06-2025 |
| Revenue: | $100,144,000 | Revenue Growth: | 87.53% |
| Revenue Growth (this year): | 25.65% | Revenue Growth (next year): | 14.81% |
Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DE GREEF RODERICK | BLFS | President and CEO | Nov 13 '25 | Sell | $25.33 | 31,165 | $789,409.45 | 389,998 | |
| DE GREEF RODERICK | BLFS | President and CEO | Nov 12 '25 | Sell | $25.88 | 33,418 | $864,857.84 | 389,998 | |
| DE GREEF RODERICK | BLFS | President and CEO | Nov 11 '25 | Sell | $26.15 | 35,417 | $926,154.55 | 389,998 | |
| GOSWAMI JOYDEEP | BLFS | Director | Oct 24 '25 | Sell | $28.99 | 1,666 | $48,297.34 | 44,986 | |
| DE GREEF RODERICK | BLFS | President and CEO | Oct 22 '25 | Sell | $27.30 | 37,795 | $1,031,803.50 | 389,998 | |
| Werner Sean | BLFS | Chief Technology Officer | Oct 20 '25 | Sell | $27.82 | 275 | $7,650.50 | 26,037 | |
| GOSWAMI JOYDEEP | BLFS | Director | Oct 16 '25 | Sell | $0.00 | 1,334 | $0.00 | 44,986 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Oct 9 '25 | Sell | $27.36 | 188 | $5,143.68 | 77,169 | |
| Berard Todd | BLFS | Chief Marketing Officer | Oct 9 '25 | Sell | $27.36 | 289 | $7,907.04 | 133,617 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Oct 9 '25 | Sell | $27.36 | 419 | $11,463.84 | 193,253 |
Latest BioLife Solutions Inc. News
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 months ago
Strong week for BioLife Solutions (NASDAQ:BLFS) shareholders doesn't alleviate pain of five-year loss
Simply Wall St.
2 months ago
BioLife Solutions And 2 Other Stocks That May Be Trading Below Their Estimated Value
Argus Research
5 months ago
BLFS: What does Argus have to say about BLFS?
Barrons.com
5 months ago
E2open Parent, Mission Produce See Activist Action
Argus Research
5 months ago
BLFS: Raising target price to $25.00
Zacks
5 months ago
How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72%
Insider Monkey
6 months ago
H.C. Wainwright Maintains Buy rating on BioLife (BLFS) Stock
Medical Device Network
6 months ago
Merit Medical acquires haemostatic device manufacturer Biolife for $120m
Compare BLFS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.